BioSpace News Archive

Handheld Imaging Devices Market: Demand for Intraoral X-ray Procedures to Fuel Market Growth

According to the report, the global handheld imaging devices market was valued at approximately ~US$ 950 Mn in 2018. It is expected to expand at a CAGR of ~13% from 2019 to 2027. Handheld imaging devices are mobile or portable imaging devices or scanners that are used to visualize internal organs or scan body parts for diagnosis of different diseases and determine an action plan for further treatment.

May 11, 2020
·
7 min read
Neurostimulation Devices Market: AI and Machine Learning Steer Innovation in Smart Neuromodulation for Brain Damage Patients

Transparency Market Research has published a new report on the neurostimulation devices market for the forecast period of 2019 - 2027.

May 11, 2020
·
7 min read
Business

ASLAN Pharmaceuticals Reports First Quarter 2020 Financial Results and Provides Corporate Update

ASLAN Pharmaceuticals, a clinical-stage immunology and oncology focused biopharmaceutical company developing innovative treatments to transform the lives of patients, reported financial results for the first quarter ended 31 March 2020 and provided an update on its clinical activities.

May 11, 2020
·
5 min read
Drug Development

Oyster Point Pharma Announces Positive Results in ONSET-2 Phase 3 Trial of OC-01 Nasal Spray for the Treatment of the Signs and Symptoms of Dry Eye Disease

ONSET-2 met the prespecified primary endpoint in both doses tested, demonstrating statistically significant improvement in Schirmer’s score from baseline to Week 4 in subjects receiving OC-01 nasal spray versus control (p<0.0001)

May 11, 2020
·
9 min read
FDA

Rutgers Clinical Genomics Laboratory Receives FDA Approval to Add Direct-to-Patient at-Home Self-Collection Saliva Kits for COVID-19 Testing Exclusively Using Spectrum Solutions™ Saliva Collection Device

Spectrum’s patented saliva preservation chemistry successfully demonstrated its unique ability to protect COVID-19 transcripts for extended periods making at-home sample collection and transport to Clinical Laboratory Improvement Amendments (CLIA) testing labs a reality.

May 11, 2020
·
4 min read
Nemaura reports positive data from early head-to-head comparison with a major incumbent CGM Device

sugarBEAT® was developed as a viable, flexible, and cost-effective alternative to invasive continuous glucose monitors, and the company plans to seek reimbursement in key territories.

May 11, 2020
·
5 min read
Business

Magellan Health Reports First Quarter 2020 Financial Results

Magellan Health, Inc. announced financial results for the first quarter ended March 31, 2020, as summarized below

May 11, 2020
·
11 min read
Business

Paratek Pharmaceuticals Announces First Quarter 2020 Total Revenues of $7.9 Million including NUZYRA® (omadacycline) Net Sales of $7.3 Million

Announced Initiation of Funding from BARDA for All FDA Required Post-Marketing Studies and Security Requirements and U.S.

May 11, 2020
·
12 min read
Genetown

Mevion Medical Systems Signs Agreement to Bring Compact Proton Therapy to Texas

Mevion Medical Systems announced that it has signed a letter of intent to provide the MEVION S250i Proton Therapy System® with HYPERSCAN® Pencil Beam Scanning to an independent service provider in Texas.

May 11, 2020
·
2 min read
Business

Amneal Reports First Quarter 2020 Financial Results

Amneal Pharmaceuticals, Inc. announced its results for the first quarter ended March 31, 2020.

May 11, 2020
·
12 min read